To Get Help Now
Fraud Lawsuits
Click Here
 
Today's Date:

New York Attorney General Sues Trump for Fraudulent University

New York’s Attorney General filed a civil lawsuit against Donald Trump, accusing him and his profit-making investment “university” of taking part in illegal, fraudulent, and deceptive activity.

The lawsuit, filed by Eric Schneiderman, seeks restitution for people across the country who were tricked into paying for a series of expensive courses that did not deliver on their promises, the New York Times reported. Trump has defended his investment course, claiming that students were 98 percent satisfied with the program.

More New York Attorney General Sues Trump for Fraudulent University

Abbott Sued for Racketeering for Its Off-Label Marketing of Epilepsy Drug Depakote

A lawsuit has been filed against Abbott Laboratories, alleging that the company was involved in racketeering when it marketed the epilepsy drug depakote for unapproved uses.

Last year, Abbott agreed to pay a $1.6 billion to settle a lawsuit charging that it promoted Depakote use to treat bipolar mania and to prevent migraine headaches, Bloomberg Businessweek reported. The settlement featured $800 million to conclude civil claims and a $700 million criminal penalty. The final $100 million was for states to resolve consumer protection matters, Bloomberg Businessweek reported.

More Abbott Sued for Racketeering for Its Off-Label Marketing of Epilepsy Drug Depakote

Studies that Once Promoted Benefits of Novartis Heart Medication Diovan Get Retracted

Researchers in Japan have withdrawn studies that promoted the benefits of one of Novartis’s top-selling drugs in the country, the heart medicine Diovan.

The retraction came after investigations found data had been tampered with to create false results, the Wall Street Journal reported. Based on the revelation, at least eight hospitals have indicated that they’ll stop prescribing Diovan. It is currently believed that there will be limited impact in the U.S. because Diovan is well established to the point that its patent has expired, according to the Wall Street Journal. The drug’s Japanese IP protection is due to end later this year.

More Studies that Once Promoted Benefits of Novartis Heart Medication Diovan Get Retracted

Judge Orders Mediation for Couple Suing J&J After Son Grew Lactating Breasts While on Risperdal

 

A couple has filed a lawsuit against a pharmaceutical company owned by Johnson & Johnson, claiming a bipolar-disorder drug caused their teenage son to develop breasts.

A Texas family told KRISTV.com that their 16-year-old son grew female breasts that began lactating after taking Risperdal for 18 months. The boy was prescribed Risperdal to treat his mood and behavioral disorders. Risperdal, which is made by Janssen Pharmaceuticals, Inc., is usually used to treat bipolar disorder. In the lawsuit, the family said this is an issue no teen should ever have to deal with.

More Judge Orders Mediation for Couple Suing J&J After Son Grew Lactating Breasts While on Risperdal

Michigan Spine Surgeon a Focal Point of DOJ’s Investigation into Physician-Owned Distributorships

The U.S. Department of Justice (DOJ) is examining physician-owned distributorships (PODs) amid concerns that the weight doctors carry with regard to hospital purchasing practices could result in serious conflict of interest.

Michigan spine surgeon Dr. Aria Sabit is at the center of the DOJ’s broader investigation of PODs, which allow doctors to take a cut of the profits, MassDevice.com reported.

More Michigan Spine Surgeon a Focal Point of DOJ’s Investigation into Physician-Owned Distributorships

Federal Antitrust Class Action Suit Filed over Alleged Ramen Noodle Price Fixing

A Koreatown market filed a federal antitrust class action against four South Korean companies alleging the companies fixed the price of instant ramen noodles for more than a decade.

The lawsuit was filed by The Plaza Company, which runs the Plaza Market in Koreatown. It names Nong Shim Co. and its Rancho Cucamonga-based subsidiary, Nong Shim America; Ottogi Co. and its Gardena subsidiary, Ottogi America; Samyang Foods Co. and Samyang USA of Santa Fe Springs; and Korea Yakult and its U.S. affiliate, Paldo America as defendants. The federal action claims that the defendants and their U.S. subsidiaries conspired six times between 2001 and 2008 to fix prices on dozens of Korean instant noodle products, resulting in price increases of nearly 54 percent, CourthouseNews.com reported.

More Federal Antitrust Class Action Suit Filed over Alleged Ramen Noodle Price Fixing

Solar Panel Industry Plagued by Quality Issues During What Should Be Boom Time

Increasing reports of solar panels faltering earlier than promised has left the solar industry anxious.

The New York Times recently chronicled the story of faulty solar panels that covered a warehouse roof in the Inland Empire region east of Los Angeles. According to the story, the panels were only two years into their expected 25-year life span when they started to fail. The coatings that protect the panels had disintegrated and other defects led to two fires that took the system offline for two years. The damage cost hundreds of thousands of dollars in lost revenues, the Times reported.

More Solar Panel Industry Plagued by Quality Issues During What Should Be Boom Time

Numerous Trucking Outfits Seek Class Action Lawsuit Against Pilot Flying J for Alleged Fraud

The number of trucking companies that have filed lawsuits against Pilot Flying J Travel Centers continues to rise.

Wright Transportation, Inc., based in Mobile County, Alabama was the latest to file a lawsuit in U.S. District Court for the Southern District of Alabama, according to NewsNet5.com. Pilot Flying J is owned by Cleveland Browns owner Jimmy Haslam.

More Numerous Trucking Outfits Seek Class Action Lawsuit Against Pilot Flying J for Alleged Fraud

It May Soon be Possible to File a Medtronic Infuse Lawsuit

Hundreds of people left frustrated by their inability to file a lawsuit against Medtronic for its Infuse, are attempting a new maneuver that may help them finally get their day in court.

To date, Infuse has never been the defendant of a personal-injury trial because of a legal concept known as “pre-emption,” the Minnesota Star Tribune reported. Pre-emption means federal law reigns over state law: The Supreme Court made a ruling that makes it nearly impossible for a person to sue for damages caused by medical devices that gained pre-market approval from the U.S. Food and Drug Administration (FDA). Now, people are attempting to get around that ruling by alleging that Medtronic marketed Infuse for off-label use, which refers to ways not approved by the FDA, according to the Star Tribune.

More It May Soon be Possible to File a Medtronic Infuse Lawsuit

55 Hospitals Pay $34 Million to Settle Charges that they Bilked Medicare Via Spinal Procedure

Fifty-five hospitals across the U.S. agreed to pay a total of $34 million to settle charges with the U.S. Justice Department that they overcharged Medicare for Medtronic’s kyphoplasty spine procedure, acquired in Medtronic’s $3.9 billion buyout of Kyphon in 2007.

The agreement ups the total settlement to $75 million from more than 100 hospitals, MassDevice.com reported. That total does not include the $75 million Medtronic paid to settle its end of the case in 2008.

More 55 Hospitals Pay $34 Million to Settle Charges that they Bilked Medicare Via Spinal Procedure